News + Filings Transactions Holdings
|
|
PERCEPTIVE ADVISORS LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
| Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
|
Cerevel Therapeutics Holdings, Inc.
| CERE | Common | 10,088,385 | 3,576,658 | 320,709,759,000 | 115,329,890,000 | | |
Hist
| 06/30/2023 |
|
Akero Therapeutics, Inc.
| AKRO | Common | 1,940,675 | 1,590,150 | 90,610,116,000 | 71,401,346,000 | | |
Hist
| 06/30/2023 |
|
Arcellx, Inc.
| ACLX | Common | 4,016,397 | 1,418,092 | 126,998,473,000 | 46,502,984,000 | | |
Hist
| 06/30/2023 |
|
Immunovant, Inc.
| | Common | 2,523,783 | 2,373,783 | 47,876,164,000 | 45,213,664,000 | | |
Hist
| 06/30/2023 |
|
CymaBay Therapeutics, Inc.
| CBAY | Common | 3,733,255 | 3,024,262 | 40,879,142,000 | 36,433,756,000 | | |
Hist
| 06/30/2023 |
|
IOVANCE BIOTHERAPEUTICS, INC.
| IOVA | COM | 14,036,410 | 4,064,630 | 98,816,326,000 | 35,096,652,000 | | |
Hist
| 06/30/2023 |
|
MeiraGTx Holdings plc
| MGTX | Common | 11,331,103 | 4,367,826 | 76,145,012,000 | 30,769,326,000 | | |
Hist
| 06/30/2023 |
|
Vaxcyte, Inc.
| PCVX | Common | 1,614,122 | 444,122 | 80,609,253,000 | 24,507,753,000 | | |
Hist
| 06/30/2023 |
|
Lyra Therapeutics, Inc.
| LYRA | Common | 12,757,562 | 3,610,832 | 52,433,579,000 | 23,712,847,000 | | |
Hist
| 06/30/2023 |
|
BridgeBio Pharma, Inc.
| BBIO | Common | 1,748,933 | 51,900 | 30,081,647,000 | 17,150,256,000 | | |
Hist
| 06/30/2023 |
|
Cabaletta Bio, Inc.
| CABA | Common | 1,545,000 | 1,227,546 | 19,945,950,000 | 17,009,500,000 | | |
Hist
| 06/30/2023 |
|
Roivant Sciences Ltd.
| ROIV | COM | 3,131,736 | 1,150,166 | 31,567,899,000 | 15,735,155,000 | | |
Hist
| 06/30/2023 |
|
Natera, Inc.
| NTRA | COMMON | 405,269 | 275,269 | 19,720,390,000 | 14,498,290,000 | | |
Hist
| 06/30/2023 |
|
Inhibrx, Inc.
| INBX | Common | 3,624,182 | 310,399 | 94,083,765,000 | 12,432,152,000 | | |
Hist
| 06/30/2023 |
|
TREACE MEDICAL CONCEPTS, INC.
| TMCI | COM | 2,217,250 | 270,847 | 56,717,255,000 | 11,969,450,000 | | |
Hist
| 06/30/2023 |
|
AMICUS THERAPEUTICS, INC.
| FOLD | COM | 27,662,917 | 20,000 | 347,446,237,000 | 9,926,220,000 | | |
Hist
| 06/30/2023 |
|
Harmony Biosciences Holdings, Inc.
| HRMY | Common | 891,370 | 479,566 | 31,367,310,000 | 8,676,910,000 | | |
Hist
| 06/30/2023 |
|
RAPT Therapeutics, Inc.
| RAPT | Common | 2,288,493 | 489,538 | 42,794,819,000 | 7,175,510,000 | | |
Hist
| 06/30/2023 |
|
Viridian Therapeutics, Inc.\DE
| VRDN | COM | 1,776,386 | 555,811 | 42,260,223,000 | 6,607,227,000 | | |
Hist
| 06/30/2023 |
|
ROCKET PHARMACEUTICALS, INC.
| RCKT | Common | 1,168,363 | 90,159 | 23,215,373,000 | 2,114,921,000 | | |
Hist
| 06/30/2023 |
|
CareMax, Inc.
| CMAX | Common | 3,817,404 | 688,209 | 11,872,126,000 | 450,564,000 | | |
Hist
| 06/30/2023 |
|
Axogen, Inc.
| AXGN | Common | 1,464,822 | 76,696 | 13,373,825,000 | -479,672,000 | | |
Hist
| 06/30/2023 |
|
|
|
|